Biogen News, Biogen Quote, BIIB Quote

Biogen (NQ:BIIB) Delayed: 198.01 -2.63 (1.31%)

Prev. Close

$200.64

Open

$198.95

52 Wk High

$333.65

52 Wk Low

$223.02

Day High

$198.95

Day Low

$197.57

P/E

25.35

EPS

$7.81

Volume

30,752

Friends, Peers and Foes (?): LLY, IONS, CRGEQ, FSLY, SAGE (more...)

Sep 5, 2024 08:53 AM BMO Capital Reiterates Outperform Rating on Biogen (BIIB)
Sep 5, 2024 06:26 AM Form 4 BIOGEN INC. For: Aug 30 Filed by: Singhal Priya
Sep 4, 2024 07:32 AM Biogen (BIIB) Reports Positive Topline Results from Study of Higher Dose Regimen of Nusinersen
Sep 4, 2024 07:30 AM Biogen Announces Positive Topline Results from Study of Higher Dose Regimen of Nusinersen, Showing Significant Benefit in Treatment of SMA
Sep 3, 2024 01:01 PM Form 144 BIOGEN INC. Filed by: Singhal Priya
Aug 22, 2024 08:06 AM BMO Capital Reiterates Outperform Rating on Biogen (BIIB)
Aug 22, 2024 05:11 AM Leqembi® (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain
Aug 14, 2024 04:31 PM Form 8-K BIOGEN INC. For: Aug 12
Aug 7, 2024 04:12 PM Form SC 13G/A BIOGEN INC. Filed by: BlackRock Inc.
Aug 6, 2024 08:16 AM Biogen (BIIB) PT Lowered to $298 at Canaccord Genuity

Entities mentioned with BIIB